Immuno Aktiengesellschaft Fur Chemischme-dizinische Produckte – Trademark Portfolio
Entity Type: 03
Immuno Aktiengesellschaft Fur Chemischme-dizinische Produckte holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include FEIBA. The owner is based in Vienna.
Industriestrasse 72
Vienna A-1220 , AT
Showing of trademarks Trademarks
Trademark Classifications
Immuno Aktiengesellschaft Fur Chemischme-dizinische Produckte's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Immuno Aktiengesellschaft Fur Chemischme-dizinische Produckte have?
Immuno Aktiengesellschaft Fur Chemischme-dizinische Produckte has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Immuno Aktiengesellschaft Fur Chemischme-dizinische Produckte file in?
Immuno Aktiengesellschaft Fur Chemischme-dizinische Produckte files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Immuno Aktiengesellschaft Fur Chemischme-dizinische Produckte's most well-known trademarks?
Immuno Aktiengesellschaft Fur Chemischme-dizinische Produckte's registered trademark portfolio includes well-known marks such as FEIBA. These are among 1 currently registered trademark in the portfolio.
What is Immuno Aktiengesellschaft Fur Chemischme-dizinische Produckte's trademark registration success rate?
Immuno Aktiengesellschaft Fur Chemischme-dizinische Produckte has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.